Home HPTN
Structure
Research
Sites
Community Ethics Prevention
Science
HPTN Studies Network
Information
Site Map

Study Status Table

 

Studies & Sites Table

 

Studies by Country

 

Studies by Research Area

 

Study Phase Definitions


HPTN 052
A Randomized Trial to Evaluate the Effectiveness of Antiretroviral Therapy Plus HIV Primary Care versus HIV Primary Care Alone to Prevent the Sexual Transmission of HIV-1 in Serodiscordant Couples

Navigation

052 Quick Links

Study Information

HPTN 052 Protocol

HPTN 052 Letters of Amendment

HPTN 052 Clarification Memos

HPTN 052 CRFs

HPTN 052 SSP

HPTN 052 Protocol Deviations

HPTN 052 Safety Information

HPTN 052 SD & Forms

HPTN 052 Resources

HPTN 052 Oversight

HPTN 052 Training

HPTN 052 Lab

HPTN 052 Q&A

HPTN 052 Recruitment Resources

HPTN 052 Related Links

HPTN 052 Alias Lists

HPTN 052 Collaboration Portal

HPTN 052 SCHARP Atlas Portal

Study Documents

The HPTN 052 study team has made the following study documents available.  When possible, documents are presented in both A4 and U.S. Letter paper sizes.  New documents will be posted here as they become available.

HPTN 052 Protocol

HPTN 052 Letters of Amendment

  • HPTN 052 V 3.0, LoA #4, 9 Dec 2008 (PDF) [U.S. Letter]
  • HPTN 052 V 3.0, LoA #3, 30 Jul 2008 (PDF) [U.S. Letter]
  • HPTN 052 V 3.0, LoA #2, 20 March 2008 (PDF) [U.S. Letter]
  • HPTN 052 V 3.0, LoA #1, 7 August 2007 (PDF) [U.S. Letter]
  • HPTN 052 V 2.0, LoA #2, 13 July 2005 (PDF) [A4] [U.S. Letter]
  • HPTN 052 V 2.0, LoA #1, 23 December 2004 (PDF) [A4] [U.S. Letter]

HPTN 052 Clarification Memos

HPTN 052 Case Report Forms (CRFs)

These CRFs are NOT to be used for data collection. They are for information purposes only. If you need CRFs that may be used for data collection, please contact Leslie Cottle at SCHARP.

HPTN 052 Study Specific Procedures Manual (SSP)
All SSP Sections are PDF files unless otherwise noted.

HPTN 052 Protocol Deviation Reporting
Instructions for protocol deviation reporting for HPTN 052 can be found in Section 3 of the HPTN 052 SSP and in Section 16 of the HPTN MOP. Protocol deviation reports should be sent to the following distribution list.  Click on each person's name to access his contact information.

*If the deviation involves an investigational product, the DAIDS protocol pharmacist(s) should be included in the distribution list.

HPTN 052 Safety Information

HPTN 052 Source Documentation and Forms
Documents are MS Word files unless otherwise noted.

HPTN 052 Resources

      

Send any questions or comments regarding this site to: hptn@fhi.org
Please read the HPTN Disclaimer

National Institutes of Health

National Institute of Allergy and Infectious Diseases

This page was last updated: December 19, 2008